Exploring Three High Growth Tech Stocks in the United States

In This Article:

Over the last 7 days, the United States market has remained flat, yet it is up 28% over the past year with earnings expected to grow by 15% per annum in the coming years. In this context of robust growth potential, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and scalability within this dynamic market environment.

Top 10 High Growth Tech Companies In The United States

Name

Revenue Growth

Earnings Growth

Growth Rating

Super Micro Computer

23.83%

24.32%

★★★★★★

Ardelyx

25.47%

69.63%

★★★★★★

Sarepta Therapeutics

23.98%

42.48%

★★★★★★

Alnylam Pharmaceuticals

22.34%

70.30%

★★★★★★

Clene

77.61%

59.19%

★★★★★★

TG Therapeutics

34.86%

56.98%

★★★★★★

Alkami Technology

21.94%

98.60%

★★★★★★

Travere Therapeutics

31.70%

72.51%

★★★★★★

Seagen

22.57%

71.80%

★★★★★★

ImmunoGen

26.00%

45.85%

★★★★★★

Click here to see the full list of 240 stocks from our US High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Alvotech

Simply Wall St Growth Rating: ★★★★★☆

Overview: Alvotech, with a market cap of $3.56 billion, develops and manufactures biosimilar medicines through its subsidiaries for patients worldwide.

Operations: The company generates revenue primarily from its biotechnology segment, amounting to $393.92 million.

Alvotech's recent strides in the biotech industry underscore its commitment to innovation, particularly in the biosimilar market. The company has seen a significant reduction in its net loss to $164.9 million from $275.17 million year-over-year, showcasing effective management and promising developments like the FDA's approval of SELARSDI for psoriatic conditions and anticipated launches aligning with U.S. market demands by Q1 2025. These efforts are complemented by a robust R&D focus, where Alvotech invests heavily; this is evident from their pipeline updates at various global healthcare conferences and strategic expansions with Teva Pharmaceutical Industries. This strategy not only bolsters their portfolio but also enhances patient access to essential treatments, potentially reshaping sector dynamics as they move towards profitability forecasted with an impressive growth rate of 99% annually.

NasdaqGM:ALVO Revenue and Expenses Breakdown as at Dec 2024
NasdaqGM:ALVO Revenue and Expenses Breakdown as at Dec 2024

Wix.com

Simply Wall St Growth Rating: ★★★★★☆

Overview: Wix.com Ltd. is a cloud-based web development platform that serves registered users and creators globally, with a market cap of approximately $12.29 billion.